Search This Blog

Monday, December 17, 2018

Amgen submits BLA for ABP 710 to FDA


Amgen announced the submission of a Biologics License Application to the U.S.FDA for ABP 710, a biosimilar candidate to REMICADE.
https://thefly.com/landingPageNews.php?id=2837929
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)